Peptide antagonists of the vasopressin-2 receptor

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9631001
SERIAL NO

14427733

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention relates to a new group of snake venom basic protease inhibitors having vasopressin-2 receptor antagonist activity that can be used in therapy, diagnosis, medical imaging, drug screening and research.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE75016 PARIS
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM)75013 PARIS
COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVESPARIS FRANCE PARIS PARIS
UNIVERSITE DE LIEGE4000 LIÈGE
UNIVERSITY OF REGENSBURGUNIVERSITÄTSSTRASSE 31 REGENSBURG 93053

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Gilles, Nicolas Mitry-Mory, FR 3 0
Mendre, Christiane Argelliers, FR 1 0
Mouillac, Bernard Montpellier, FR 2 2
Quinton, Loïc Stree-Lez-Huy, BE 1 0
Reinfrank, Helen Kofering, DE 1 0
Servent, Denis Versailles, FR 5 3
Witzgall, Ralph Regensburg, DE 1 0

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Oct 25, 2028
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00